Navigation Links
Inovio Pharmaceuticals Reports 2013 First Quarter Financial Results

License fee and milestone revenue from affiliated entity

106,250106,250Grants and miscellaneous revenue

1,334,7161,562,033Total revenues1,455,2251,693,121Operating expenses:Research and development

5,115,1124,042,579General and administrative

2,974,1532,488,088Gain on sale of assets

—(651,000)Total operating expenses8,089,2655,879,667Loss from operations(6,634,040)(4,186,546)Other income (expense):Interest and other income, net

39,46031,544Change in fair value of common stock warrants

(1,427,616)(3,548,173)Loss on investment in affiliated entity

(836,084)(561,544)Net loss(8,858,280)(8,264,719)Net loss attributable to non-controlling interest

14,1609,770Net loss attributable to Inovio Pharmaceuticals, Inc.$


(8,254,949)Loss per common share—basic and diluted:Net loss per share attributable to Inovio Pharmaceuticals, Inc. stockholders$


(0.06)Weighted average number of common shares outstanding—basic and diluted156,155,532134,968,394CONTACTS:
Investors: Bernie Hertel, Inovio Pharmaceuticals, 858-410-3101,
Media: Jeff Richardson, Inovio Pharmaceuticals, 267-440-4211,


SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Inovio Pharmaceuticals Promotes Niranjan Sardesai to Chief Operating Officer
2. Inovio Pharmaceuticals to Present at Noble Financial 8th Annual Equity Conference
3. Inovios Scientific Advisory Board Chairman Elected as a Fellow by the American Association for the Advancement of Science
4. Inovio Pharmaceuticals to Present at Noble Financial Life Sciences Conference
5. Inovio Pharmaceuticals Cytomegalovirus (CMV) Synthetic Vaccine Constructs Generate Strong and Broad T-Cell Responses in Preclinical Study
6. Inovio Pharmaceuticals Announces Positive Interim Results in Phase II Leukemia Trial
7. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
8. Convergence Pharmaceuticals Initiates Phase I Multiple Ascending Dose Study for CNV2197944
9. TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML)
10. Questcor Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011
11. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
Post Your Comments:
(Date:7/24/2014)... Three companies from the angelMD network were ... Competition. Out of 700 competition entrants, Chiron Health, Litesprite, ... round. In this round twenty teams are invited to ... mentoring from thought-leaders and medical entrepreneurs from all over ... commitment to the Livestrong vision around the Big C ...
(Date:7/24/2014)... , July 24, 2014  Neogen Corporation (Nasdaq: ... forecasts of its potential revenue from new rodenticide research ... investors and analysts on July 22, 2014, Neogen,s CEO ... regarding this research. "It was my intent ... the potential of a new type of rodenticide, but ...
(Date:7/24/2014)... 1000 balances – 4 steps – ... weighing needs and expertly narrows down the mass of ... or even terminals. , First, select the working ... select readability instead) and define the accuracy – it’s ... narrows down the list to models that fit best ...
(Date:7/24/2014)... San Francisco, CA (PRWEB) July 24, 2014 ... entrepreneurship , is proud to announce ... entrepreneurs from 17 different countries will converge on ... Silicon Valley for an intensive, experiential program focused ... doing.” The highly selective school, currently running its ...
Breaking Biology Technology:3 angelMD Startups Make Livestrong Big C Semi-finals 2Neogen comments on SenesTech 2Summer Entrepreneurship Program Kicked Off by Draper University in Silicon Valley 2Summer Entrepreneurship Program Kicked Off by Draper University in Silicon Valley 3
... 18 Solvay Pharmaceuticals announces it has signed ... specialized in enabling and accelerating global codevelopment of ... this agreement, Solvay Pharmaceuticals will gain access to ... compounds in the cardiovascular area. As some ...
... Community to Join a Nationwide Network of Independence Day ... Development Institute (ALS TDI) announced its BBQ For ... increase the awareness and understanding of ALS (amyotrophic lateral ... its goal, the campaign brings together three undoubtedly American ...
... Cumberland Pharmaceuticals announced today the launch of ... Acetadote (acetylcysteine) Injection , the company,s ... )Available at ... hospital pharmacists and physicians, educators and other healthcare ...
Cached Biology Technology:Solvay Pharmaceuticals Announces Strategic Partnership With HUYA to Access new Drug Candidates From China 2Solvay Pharmaceuticals Announces Strategic Partnership With HUYA to Access new Drug Candidates From China 3Campaign to Increase the Awareness and Understanding of Lou Gehrig's Disease Reaches 22 U.S. States 2Campaign to Increase the Awareness and Understanding of Lou Gehrig's Disease Reaches 22 U.S. States 3Cumberland Pharmaceuticals Provides Hospital In-Service Webcast for Acetadote(R) 2Cumberland Pharmaceuticals Provides Hospital In-Service Webcast for Acetadote(R) 3
(Date:7/24/2014)... identified two factors that characterize sustainable university and ... highly qualified physics teachers. Specifically, one or more ... education in combination with institutional motivation and commitment ... Technology, Engineering and Math (STEM) teacher shortages are ... the way for institutions seeking to increase the ...
(Date:7/24/2014)... A multi-institutional team of researchers has developed a ... This safe, noninvasive method for assessing the function and ... lead to better diagnosis and treatment of gut diseases. ... overgrowth, irritable bowel syndrome and inflammatory bowel disease all ... side effects in patients with diseases such as diabetes ...
(Date:7/24/2014)... The Atlantic Forest is a hotspot of biodiversity and ... (frogs, tree-frogs, and toads) in the world. However, current ... past few years has been an increase in the ... with the advance of molecular techniques and availability of ... extensive number of samples for molecular and morphological analysis, ...
Breaking Biology News(10 mins):Creating sustainable STEM teacher preparation programs 2New imaging agent provides better picture of the gut 2A tiny new species of frog from Brazil with a heroic name 2
... For winter sports athletes, including Olympians competing in Vancouver ... have a significant impact on performance, requiring athletes in ... snowboarding, to retool highly technical moves to accommodate more ... and benefits of training and performing at sea level ...
... greatly benefit the U.S., say scientists in an Energy ... America (ESA), the nation,s largest organization of ecological scientists. ... economic benefits of biofuel production, U.S. policies need to ... In the report, scientists Virginia Dale, Keith Kline, ...
... JOLLA, Calif., February 12, 2010 An international team ... Burnham Institute for Medical Research), Nijmegen Centre for Molecular ... a protein implicated in cancer metastasis, also plays a ... fatal disorder. The research was published on February 12 ...
Cached Biology News:Winter Olympics: Altitude affects skill sports, not just endurance events 2Winter Olympics: Altitude affects skill sports, not just endurance events 3Beyond the corn field: Balancing fuel, food and biodiversity 2Researchers identify mechanism for Frank-Ter Haar syndrome 2
... NPY Y2 Receptor antiserum This NPY ... spinal level and is currently being characerized in ... rat and mouse and appears to work better ... in rat. For full characterizarion in dorsal root ...
RECK (F-20)...
Black Polypropylene 384 Round Well Plate 70/Box...
... polyclonal to Peroxiredoxin 1 Peroxiredoxin ... whose mammalian members have been known ... and apoptosis. Many isoforms (about 50 ... amino acid sequence homology, particularly amino-terminal ...
Biology Products: